发明名称 APROTININ MUTANT HAVING IMPROVED CHARACTERISTICS
摘要 <p>PROBLEM TO BE SOLVED: To obtain the novel subject mutant which has a positive charge in the neutral pH region, contains a specific mutation of amino acid in the binding region, has improved enzyme-inhibitory, immunological and pharmacodynamic properties and is useful for treatment of surgery operation, multiple trauma, inflammation and the like. SOLUTION: This novel aprotinin mutant has a positive charge of +3--3 at pH 7 and contains the amino acid(s) of Arg 15 or of Arg 15-Ala 17 in the binding region and shows improved enzyme-inhibitory, immunological and pharmacodynamic properties and is useful as a medicine for treatment of surgery operation, reduction of blood loss, multiple trauma, shock and inflammation. This aprotinin mutant is obtained by cloning a vector containing the aprotinin gene using a partial gene of aprotinin, inducing the site-specific mutation of the cloned gene by the PCR technique using the mutation-inducing primer and the selection primer and integrating the gene into a vector and expressing the gene in the host cells.</p>
申请公布号 JPH10101700(A) 申请公布日期 1998.04.21
申请号 JP19970210197 申请日期 1997.07.22
申请人 BAYER AG 发明人 SCHROEDER WERNER DR;BJOERN SOEREN;NORRIS KJELD;DINESS VIGGO;NOERKSKOV-LAURITSEN LEIF;CHRISTENSEN NIELS DYHR
分类号 C12N15/09;A61K38/00;A61K38/04;A61K38/10;A61K38/55;A61K38/57;A61P7/04;A61P17/00;A61P29/00;A61P43/00;C07K14/00;C07K14/81;C12N15/15;(IPC1-7):C07K14/81 主分类号 C12N15/09
代理机构 代理人
主权项
地址